Recombinant erythropoietin in clinical practice
Data up to Jan 2025
Total Citations Per Year
Abstract
References (102)
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
1987 • 2,006 citations
EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS
1986 • 1,412 citations
Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
2002 • 1,221 citations
Erythropoietin: structure, control of production, and function
1992 • 1,158 citations
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
2002 • 1,038 citations
Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal Disease
1989 • 793 citations
Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.
1998 • 769 citations
Decreased Erythropoietin Response in Patients with the Anemia of Cancer
1990 • 680 citations
Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy
2002 • 428 citations
Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma
2002 • 389 citations
Efficacy of erythropoietin in the myelodysplastic syndromes: a meta‐analysis of 205 patients from 17 studies
1995 • 359 citations
Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial
1999 • 353 citations
Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2
1996 • 348 citations
Erythroid response to treatment with G‐CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model
1997 • 317 citations
The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron
2002 • 264 citations
Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients
2000 • 240 citations
Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response
1995 • 226 citations
Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma
1996 • 210 citations
Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination Chemotherapy
1993 • 207 citations
Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.
1994 • 205 citations
Anemia and Survival in HIV Infection
1998 • 194 citations
Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients
2001 • 192 citations
Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency
2001 • 191 citations
Recombinant Human Erythropoietin in the Treatment of Anemia Associated with Human Immunodeficiency Virus (HIV) Infection and Zidovudine Therapy
1992 • 185 citations
The importance of anemia and its correction in the management of severe congestive heart failure
2002 • 178 citations
Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients
2001 • 172 citations
Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models
2001 • 163 citations
Erythropoietin enhances recovery after cisplatin‐induced acute renal failure in the rat
2001 • 132 citations
Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia.
1997 • 129 citations
Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease
1989 • 129 citations
Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight
2000 • 127 citations
Antibodies against rHuEPO: native and recombinant
2002 • 122 citations
Chromosomal assignment of the human erythropoietin gene and its DNA polymorphism.
1986 • 116 citations
Pure Red Cell Aplasia
1979 • 109 citations
The effect of the transfusion of stored RBCs on intestinal microvascular oxygenation in the rat
2001 • 109 citations
Obesity as a risk factor in renal transplant patients
2001 • 108 citations
Recombinant human erythropoietin and the anemia of cancer [editorial]
1994 • 107 citations
The impact of hemoglobin levels on treatment outcomes in patients with cancer
2001 • 106 citations
Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood
2000 • 102 citations
Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy
1998 • 97 citations
Evidence-based recommendations for the clinical use of recombinant human erythropoietin
1995 • 96 citations
An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP)
2001 • 91 citations
Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer
2001 • 88 citations
Recombinant human erythropoietin and the anemia of cancer [editorial]
1994 • 87 citations
CMV and blood transfusions
2002 • 84 citations
A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy
2001 • 83 citations
Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary?
2001 • 80 citations
The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
2001 • 77 citations
Red Blood Cell Function and Blood Storage
2000 • 73 citations
Autologous transfusion
2004 • 69 citations
Practical Transfusion Medicine
2005 • 68 citations
Beyond erythropoiesis: Novel applications for recombinant human erythropoietin
2001 • 65 citations
Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis
2000 • 64 citations
Consensus statement: Anemia in HIV infection—current trends, treatment options, and practice strategies
2000 • 63 citations
Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure
2001 • 62 citations
The production of recombinant human erythropoietin
1995 • 62 citations
Red Blood Cell Function and Blood Storage
2000 • 60 citations
Unexpected Renal Actions of Erythropoietin
2002 • 57 citations
The effectiveness and tolerability of epoetin alfa in patients with multiple myeloma refractory to chemotherapy
1998 • 51 citations
The erythropoietin receptor
1999 • 50 citations
Erythropoietin and Neonatal Anemia
1994 • 49 citations
Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measures
1999 • 48 citations
The Role of Recombinant Human Erythropoietin in the Treatment of Thalassemia
1998 • 48 citations
Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
1998 • 48 citations
Blood boosting and sport
2000 • 47 citations
Subcutaneous Low-Dose Epoetin Beta for the Avoidance of Transfusion in Patients Scheduled for Elective Surgery Not Eligible for Autologous Blood Donation
2001 • 44 citations
Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies. final results of a randomized phase III study
2001 • 44 citations
Recombinant human erythropoietin administration in cardiac surgery
2001 • 44 citations
Plasma total homocysteine concentration in nephrotic patients with idiopathic membranous nephrophathy
2001 • 43 citations
Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
1993 • 42 citations
Erythropoietin: the promise and the facts.
1994 • 41 citations
Pure Red Cell Aplasia as Presentation of Systemic Lupus Erythematosus: Antibodies to Erythropoietin: CASE REPORT
1999 • 40 citations
Erythropoietin and renal transplantation
1999 • 38 citations
Cardiovascular Mortality in Haemodialysis Patients Treated with Epoetin Beta – A Retrospective Study
2000 • 38 citations
Abnormal renal phenotype in L1 knockout mice: a novel cause of CAKUT
2002 • 36 citations
The importance of early treatment of the anaemia of chronic kidney disease
2001 • 33 citations
Meeting the challenges of a new millennium: optimizing the use of recombinant human erythropoietin
1998 • 29 citations
Intensive Care Unit Patients
2010 • 28 citations
Practical Transfusion Medicine
2006 • 27 citations
Recombinant Human Erythropoietin Treatment: Investigational New Drug Protocol for the Anemia of the Acquired Immunodeficiency Syndrome
1993 • 26 citations
Primary and Revision Total Hip Replacement in Patients Who Are Jehovah's Witnesses
1999 • 26 citations
Long-term follow-up of 18 patients with myelodysplastic syndromes responding to recombinant erythropoietin treatment
2001 • 25 citations
Randomised controlled double blind study of role of recombinant erythropoietin in the prevention of chronic lung disease
1997 • 24 citations
Use of Erythropoietin and Its Effects on Blood Lactate and 2,3-Diphosphoglycerate in Premature Neonates
2000 • 24 citations
Effect of recombinant human erythropoietin on lymphocyte phenotyping and phagocyte activity in hemodialysis patients
1997 • 24 citations
Open-heart surgery in Jehovah's Witness patients
1996 • 22 citations
Anemia in inflammatory bowel disease – the role of recombinant human erythropoietin
2000 • 22 citations
Continuous Intravenous Sodium Ferric Gluconate Improves Efficacy in the Maintenance Phase of EPOrHu Administration in Hemodialysis Patients
2002 • 20 citations
Erythropoietin can obviate the need for repeated heart valve replacement in high-risk patients with severe mechanical hemolytic anemia: case reports and literature review.
2001 • 19 citations
Blood transfusion in marrow graft recipients
1992 • 16 citations
THE USE OF PRETRANSPLANT ERYTHROPOIETIN TO NORMALIZE HEMOGLOBIN LEVELS HAS NO DELETERIOUS EFFECTS ON RENAL TRANSPLANTATION OUTCOME1
2001 • 16 citations
Anaemia of Prematurity
1997 • 16 citations
Comparison of Intraperitoneal and Subcutaneous Epoetin Alfa in Peritoneal Dialysis Patients
1999 • 14 citations
Clinical use of rHuEPO in bone marrow transplantation
1999 • 13 citations
Allogeneic blood transfusion as a risk factor for the subsequent development of non-Hodgkin's lymphoma
2000 • 12 citations
Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer. Implications for use in gynecologic surgery.
2001 • 11 citations
Beyond erythropoiesis: Novel applications for recombinant human erythropoietin
2001 • 10 citations
Recombinant erythropoietin for prevention of anemia in preterm infants
1995 • 8 citations
Factors Associated with Successful Epoetin Alfa Therapy in Premature Infants
2000 • 6 citations
[Prevention of neonatal anemia with recombinant human erythropoietin: a cost-benefit analysis].
1999 • 2 citations
Blood Transfusion Policy
1989 • 1 citations
Deleted Work
1955 • 0 citations